Dernières nouvelles
Information non disponible
A scintillation dosimeter with real-time positional tracking information for in vivo dosimetry error detection in HDR brachytherapy
Article de revueJ Appl Clin Med Phys, 2023.
Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial
Article de revueClin Transl Radiat Oncol, 40 , 2023.
Commissioning of an intra-operative US guided prostate HDR system integrating an EM tracking technology
Article de revueBrachytherapy, 20 (6), 2021.
Performance of an enhanced afterloader with electromagnetic tracking capabilities for channel reconstruction and error detection
Article de revueMed Phys, 48 (8), 2021.
Dose to the bladder neck is not correlated with urinary toxicity in patients with prostate cancer treated with HDR brachytherapy boost
Article de revueBrachytherapy, 19 (5), 2020.
Impact of a dominant intraprostatic lesion (DIL) boost defined by sextant biopsy in permanent I-125 prostate implants on biochemical disease free survival (bDFS) and toxicity outcomes
Article de revueRadiother Oncol, 133 , 2019.
Does Seed Migration Increase the Risk of Second Malignancies in Prostate Cancer Patients Treated With Iodine-125 Loose Seeds Brachytherapy?
Article de revueInt J Radiat Oncol Biol Phys, 100 (5), 2018.
High-dose-rate brachytherapy boost for prostate cancer treatment: Different combinations of hypofractionated regimens and clinical outcomes
Article de revueRadiother Oncol, 124 (1), 2017.
Use of 3D transabdominal ultrasound imaging for treatment planning in cervical cancer brachytherapy: Comparison to magnetic resonance and computed tomography
Article de revueBrachytherapy, 16 (4), 2017.
Image-Guided High-Dose-Rate (HDR) Boost Localization Using MRI/MR Spectroscopy: A Correlation Study with Biopsy
Article de revueCureus, 8 (9), 2016.